新型冠状病毒肺炎患者的随访：狼疮抗凝物是短暂的，但其他抗磷脂抗体是持续存在的。 - Suppr

Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent.

作者信息

Vollmer Olivier, Tacquard Charles, Dieudonné Yannick, Nespola Benoit, Sattler Laurent, Grunebaum Lélia, Gies Vincent, Radosavljevic Mirjana, Kaeuffer Charlotte, Hansmann Yves, Weber Jean-Christophe, Martin Thierry, Arnaud Laurent, Morel Olivier, Guffroy Aurélien, Collange Olivier, Mertes Paul Michel, Korganow Anne-Sophie, Delabranche Xavier, Poindron Vincent

机构信息

Service d'Immunologie Clinique-Médecine Interne, Centre National de Référence des Maladies Auto-immunes et Systémiques Rares Est/Sud-Ouest RESO, Hôpitaux Universitaires de Strasbourg, France.

Service d'Anesthésie-Réanimation, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

出版信息

Autoimmun Rev. 2021 Jun;20(6):102822. doi: 10.1016/j.autrev.2021.102822. Epub 2021 Apr 16.

DOI:10.1016/j.autrev.2021.102822

PMID:33872769

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8050395/

Abstract

摘要

相似文献

Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent.

Autoimmun Rev. 2021 Jun;20(6):102822. doi: 10.1016/j.autrev.2021.102822. Epub 2021 Apr 16.

Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy.

Arthritis Rheumatol. 2021 Jan;73(1):173-174. doi: 10.1002/art.41472. Epub 2020 Dec 5.

Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature.

Semin Thromb Hemost. 2022 Feb;48(1):55-71. doi: 10.1055/s-0041-1729856. Epub 2021 Jun 15.

Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre.

Autoimmun Rev. 2022 Dec;21(12):103208. doi: 10.1016/j.autrev.2022.103208. Epub 2022 Oct 3.

Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.

Autoimmunity. 2009 Sep;42(6):497-506. doi: 10.1080/08916930902882731.

[Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].

Harefuah. 2001 Jun;140(6):495-500, 565.

The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.

Verh K Acad Geneeskd Belg. 2000;62(5):353-72.

Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies.

Front Immunol. 2022 Sep 15;13:953043. doi: 10.3389/fimmu.2022.953043. eCollection 2022.

[Antiphospholipid antibodies: what is new in 2022].

Ann Biol Clin (Paris). 2022 Jul 1;80(4):333-343. doi: 10.1684/abc.2022.1745.

Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis.

Autoimmun Rev. 2014 Jun;13(6):595-608. doi: 10.1016/j.autrev.2013.11.004. Epub 2014 Jan 11.

引用本文的文献

The New Occurrence of Antiphospholipid Syndrome in Severe COVID-19 Cases with Pneumonia and Vascular Thrombosis Could Explain the Post-COVID Syndrome.

Biomedicines. 2025 Feb 19;13(2):516. doi: 10.3390/biomedicines13020516.

Antiphospholipid Antibodies and COVID-19: A Systematic Review of Clinical Implications.

Immun Inflamm Dis. 2025 Feb;13(2):e70134. doi: 10.1002/iid3.70134.

Persistent Lupus Anticoagulant Positivity and Long-Term Sequelae Following Mild COVID-19.

Cureus. 2024 Oct 29;16(10):e72668. doi: 10.7759/cureus.72668. eCollection 2024 Oct.

Antiphospholipid antibody-related hepatic vasculitis in a juvenile after non-severe COVID-19: a case report and literature review.

Front Immunol. 2024 Apr 19;15:1354349. doi: 10.3389/fimmu.2024.1354349. eCollection 2024.

Prevalence and Impact of Lupus Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation.

Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231207062. doi: 10.1177/10760296231207062.

Prevalence, clinical significance, and persistence of autoantibodies in COVID-19.

Virol J. 2023 Oct 16;20(1):236. doi: 10.1186/s12985-023-02191-z.

Thrombosis and Hyperinflammation in COVID-19 Acute Phase Are Related to Anti-Phosphatidylserine and Anti-Phosphatidylinositol Antibody Positivity.

Biomedicines. 2023 Aug 18;11(8):2301. doi: 10.3390/biomedicines11082301.

Molecular mimicry and autoimmunity in the time of COVID-19.

J Autoimmun. 2023 Sep;139:103070. doi: 10.1016/j.jaut.2023.103070. Epub 2023 Jun 12.

Evaluation of the Association between Antiphospholipid Antibodies and ICU Admission Outcome in Critically Ill COVID-19 Patients in Iranian Population.

Int J Prev Med. 2022 Nov 23;13:140. doi: 10.4103/ijpvm.ijpvm_518_21. eCollection 2022.

COVID-19 and antiphospholipid antibodies.

Best Pract Res Clin Haematol. 2022 Sep;35(3):101402. doi: 10.1016/j.beha.2022.101402. Epub 2022 Oct 15.

本文引用的文献

Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward.

Autoimmun Rev. 2021 Feb;20(2):102729. doi: 10.1016/j.autrev.2020.102729. Epub 2020 Dec 13.

Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020.

Euro Surveill. 2020 Dec;25(48). doi: 10.2807/1560-7917.ES.2020.25.48.2000895.

Severe COVID-19: A multifaceted viral vasculopathy syndrome.

Ann Diagn Pathol. 2021 Feb;50:151645. doi: 10.1016/j.anndiagpath.2020.151645. Epub 2020 Oct 13.

Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19.

Sci Transl Med. 2020 Nov 18;12(570). doi: 10.1126/scitranslmed.abd3876. Epub 2020 Nov 2.

Lupus Anticoagulant in Patients with Covid-19. Reply.

N Engl J Med. 2020 Nov 5;383(19):1893-1894. doi: 10.1056/NEJMc2027508. Epub 2020 Oct 23.

Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine.

Immunol Res. 2020 Oct;68(5):310-313. doi: 10.1007/s12026-020-09152-6. Epub 2020 Sep 18.

Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19).

JAMA Netw Open. 2020 Aug 3;3(8):e2017539. doi: 10.1001/jamanetworkopen.2020.17539.

Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?

Thromb Res. 2020 Nov;195:74-76. doi: 10.1016/j.thromres.2020.07.016. Epub 2020 Jul 8.

Anticardiolipin IgG Autoantibody Level Is an Independent Risk Factor for COVID-19 Severity.

Arthritis Rheumatol. 2020 Nov;72(11):1953-1955. doi: 10.1002/art.41409. Epub 2020 Sep 22.

Covid-19 and autoimmunity.

Autoimmun Rev. 2020 Aug;19(8):102597. doi: 10.1016/j.autrev.2020.102597. Epub 2020 Jun 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献